These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28653873)

  • 1. The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous?
    Ou Q; Cheng J; Zhang L; Wang H; Wang W; Ma Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706214. PubMed ID: 28653873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancer.
    Nakano K; Hosoda M; Yamamoto M; Yamashita H
    Anticancer Res; 2014 Jul; 34(7):3819-24. PubMed ID: 24982408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.
    Suppan C; Bjelic-Radisic V; La Garde M; Groselj-Strele A; Eberhard K; Samonigg H; Loibner H; Dandachi N; Balic M
    BMC Cancer; 2015 Dec; 15():1027. PubMed ID: 26715527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer.
    Koh CH; Bhoo-Pathy N; Ng KL; Jabir RS; Tan GH; See MH; Jamaris S; Taib NA
    Br J Cancer; 2015 Jun; 113(1):150-8. PubMed ID: 26022929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
    Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer.
    Yoo EJ; Park JC; Kim EH; Park CH; Shim CN; Lee HJ; Chung HS; Lee H; Shin SK; Lee SK; Lee CG; Lee YC
    Dig Liver Dis; 2014 Sep; 46(9):846-53. PubMed ID: 24970014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neutrophil/lymphocyte ratio in complete blood count as a mortality predictor in breast cancer].
    Mimica X; Acevedo F; Oddo D; Ibáñez C; Medina L; Kalergis A; Camus M; Sánchez C
    Rev Med Chil; 2016 Jun; 144(6):691-6. PubMed ID: 27598486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer.
    Li H; Song J; Cao M; Wang G; Li L; Zhang B; Li Y; Xu W; Zheng J
    Int Immunopharmacol; 2016 Nov; 40():327-331. PubMed ID: 27664571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils, G-CSF and their contribution to breast cancer metastasis.
    Mouchemore KA; Anderson RL; Hamilton JA
    FEBS J; 2018 Feb; 285(4):665-679. PubMed ID: 28834401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
    PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.
    Taguchi S; Nakagawa T; Matsumoto A; Nagase Y; Kawai T; Tanaka Y; Yoshida K; Yamamoto S; Enomoto Y; Nose Y; Sato T; Ishikawa A; Uemura Y; Fujimura T; Fukuhara H; Kume H; Homma Y
    Int J Urol; 2015 Jul; 22(7):638-43. PubMed ID: 25903328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour site.
    Takakura K; Ito Z; Suka M; Kanai T; Matsumoto Y; Odahara S; Matsudaira H; Haruki K; Fujiwara Y; Saito R; Gocho T; Nakashiro K; Hamakawa H; Okamoto M; Kajihara M; Misawa T; Ohkusa T; Koido S
    Scand J Gastroenterol; 2016; 51(5):610-7. PubMed ID: 26679084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer.
    Asano Y; Kashiwagi S; Onoda N; Noda S; Kawajiri H; Takashima T; Ohsawa M; Kitagawa S; Hirakawa K
    Ann Surg Oncol; 2016 Apr; 23(4):1104-10. PubMed ID: 26511266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.
    Kao SC; Pavlakis N; Harvie R; Vardy JL; Boyer MJ; van Zandwijk N; Clarke SJ
    Clin Cancer Res; 2010 Dec; 16(23):5805-13. PubMed ID: 20956618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between lifestyles and neutrophil-lymphocyte and platelet-lymphocyte ratios in colorectal cancer.
    Hong C; Wei Y; Jiang J; Zhao C; Liang G; Wang G; Yang H
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):168-74. PubMed ID: 23714008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between neutrophil to lymphocyte ratio and survival in metastatic breast cancer patients.
    Unlu O; Petekkaya E; Ozcan B; Altundag K
    J BUON; 2016; 21(5):1322-1323. PubMed ID: 27837641
    [No Abstract]   [Full Text] [Related]  

  • 20. The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?
    Kim EY; Lee JW; Yoo HM; Park CH; Song KY
    Ann Surg Oncol; 2015 Dec; 22(13):4363-70. PubMed ID: 25805235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.